Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/CABALETTA-BIO-INC-70835225/news/Cabaletta-Bio-Inc-erhalt-weitere-FDA-Fast-Track-Designations-fur-CABA-201-bei-Dermatomyositis-un-45692282/?utm_source=whatsapp&utm_medium=social&utm_campaign=share